End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.97 CNY | +3.85% | +8.02% | -7.08% |
25/04 | Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug | MT |
Business Summary
Number of employees: 6,208
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vitamin E
35.7
%
| 3,450 | 42.7 % | 2,785 | 35.7 % | -19.27% |
Social Delivery Series
28.8
%
| 2,137 | 26.5 % | 2,244 | 28.8 % | +5.03% |
Other
7.3
%
| 473 | 5.9 % | 565 | 7.3 % | +19.59% |
Vitamin A
6.4
%
| 514 | 6.4 % | 495 | 6.4 % | -3.71% |
Levofloxacin Series
5.7
%
| 390 | 4.8 % | 442 | 5.7 % | +13.46% |
Vancomycin Hydrochloride
5.1
%
| 381 | 4.7 % | 399 | 5.1 % | +4.64% |
Nerofloxacin Malate Series
4.2
%
| 174 | 2.2 % | 325 | 4.2 % | +87.06% |
Miglitol Series
2.8
%
| 235 | 2.9 % | 222 | 2.8 % | -5.58% |
Teicoplanin Series
2.3
%
| 179 | 2.2 % | 183 | 2.3 % | +1.82% |
Progesterone Series
1.0
%
| 99 | 1.2 % | 77 | 1.0 % | -22.72% |
Other Business
0.4
%
| 43 | 0.5 % | 32 | 0.4 % | -25.71% |
Daptomycin API
0.3
%
| - | - | 26 | 0.3 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
72.3
%
| 5,347 | 66.2 % | 5,633 | 72.3 % | +5.35% |
Overseas
39.4
%
| 3,912 | 48.5 % | 3,069 | 39.4 % | -21.55% |
Inter-segment Offset
-11.6
%
| -1,186 | -14.7 % | -908 | -11.6 % | -23.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 01/06/01 |
Nan Xing Li
BRD | Director/Board Member | 38 | 11/15/11 |
Ke Qiu
IRC | Investor Relations Contact | - | - |
Wei Dong Ye
SEC | Corporate Secretary | 61 | 01/90/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Bo Li
CHM | Chairman | 65 | 01/97/01 |
Nai Wei Chen
BRD | Director/Board Member | 67 | 15/18/15 |
Chun Lei Lu
CEO | Chief Executive Officer | 57 | 01/06/01 |
Xiao Ming Wu
BRD | Director/Board Member | 69 | 15/21/15 |
Yi Zheng Qiu
BRD | Director/Board Member | 50 | 16/21/16 |
Yun Feng Liu
BRD | Director/Board Member | 55 | 16/21/16 |
Zhen Hua Chu
BRD | Director/Board Member | 42 | 16/21/16 |
Yu Qing Yu
BRD | Director/Board Member | 47 | 16/21/16 |
Hong Yu Cang
BRD | Director/Board Member | 41 | 06/23/06 |
Qing Xia
BRD | Director/Board Member | 47 | 16/21/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 964,975,000 | 565,549,504 ( 58.61 %) | 3,337,250 ( 0.3458 %) | 58.61 % |
Company contact information
Zhejiang Medicine Co., Ltd.
168 Zhiyuan Middle Avenue Binhai New City
312366, Shaoxing
+86 575 8521 1979
http://www.zmc.topSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.08% | 1.32B | |
+31.82% | 699B | |
+26.11% | 571B | |
-4.34% | 364B | |
+18.01% | 326B | |
+2.28% | 286B | |
+14.62% | 236B | |
+4.45% | 198B | |
-11.66% | 194B | |
-4.58% | 154B |
- Stock Market
- Equities
- 600216 Stock
- Company Zhejiang Medicine Co., Ltd.